Good afternoon, chair, postman and members during the volunteer. We are in the throes of implementing all of the work that the legislature gave us this past session, including a lot of rulemaking work on the 2023 legislation, specifically the THC bill in social equity, that you'll hear about from Justin that you've been hearing about at board meetings. One of the specific things that we do each year is to summarize the bill that get passed to get our view of what the law chains really mean and how we're going to implement them. These are called the legislative fact sheets, kind of simple one, two page summaries of bills impacting the LCD. And I'll show one of them here, in part because I'm gonna remind you of the look and feel. And when Brian gets here, he can come update you on when they're gonna be posted. But I'm told it's imminently like today or tomorrow. And then also to take this opportunity to remind you about the medical cannabis excise tax exemption. So Dustin, I don't know if you have that documented and share that. Thank you. So we talked about it on Tuesday caucus and Justin talked about it at this morning's board meeting. But to ensure that we comply with what we'll call the frost rule and mentioned it seven times in seven different ways. Let's do it again. So again, the exemption only applies when each of three conditions are met. For the first of the store offering the exemption must be medically endorsed. Second, that the purchaser must be in the Department of Health's registry, they must be a color card holding patient with a qualifying condition. And third, that the product they bind must be medically compliant per the Department of Health. And we've got the the whack referenced in the text that you see on the screen. So it must have undergone the additional testing that that the Department of Health requires. We'll just know that this is different from the way and we talked about this on Tuesday. This is different from the way that the Department of Health and Department of Revenue implemented the sales tax exemption for medical cannabis. So this is going to be a little bit different. So again, more to come on this topic as we try to ensure that patients know how this will work. And that retailers know how it works. So they don't have expensive tax bills down the road if they do it wrong. And as you may know, the state's revenue forecasters have been looking into this topic and tried to anticipate what kind of revenue impact it will have on the dedicated cannabis account. And their best estimates are a part of the budget outlook that the economic and revenue forecast Council just adopted in late April. Of course, we can't focus solely on implementation, we need to be getting ready for 2025. And you can stop sharing now. The divisions that started that work, and of course, we're going to be hearing from legislators about ideas for next session, including, you know, I think a number of things that were introduced but didn't pass in 2024. Director Lukela and I are hoping to get out and meet with members of the legislature. And we can bring back to you some of the ideas that they're mulling over. We can also convey messages about what's important to you as a board and where you're going to be putting your effort in the coming session. We have plenty of time this point to develop ideas, but it's sadly not unlimited. The governor's office has deadlines, and there's a lot of process steps to move through. If we want to go down the path of agency request legislation. We're going to be able to flush that timeline out throughout the summer, and CFO Rachel Swanner. and I are trying as best we can to kind of align the timelines for both agency request legislation and budget requests as much as we can, knowing that a couple of those things are gonna be in both buckets. Right? If there's an agency request a proposal that has a fiscal impact, it's going to be both a decision package and a bill. So we really need to hear from you. What are you hearing about what do you think we should step up and advocate for? I'm going to try to schedule meetings to discuss this with you in the short term. And again, bring what we're hearing from our industry partners, or public health partners, and more to try to shape our 2025 agenda. That's all I have for now and I'd be happy to answer any questions. Have